Skip to main content
Observe Medical logo

Observe Medical — Investor Relations & Filings

Ticker · OBSRV ISIN · NO0010865009 LEI · 9845005F38B74FFJ1B65 Euronext Expand Manufacturing
Filings indexed 643 across all filing types
Latest filing 2023-12-12 Regulatory Filings
Country NO Norway
Listing Euronext Expand OBSRV

About Observe Medical

https://observemedical.com/

Observe Medical is a medical technology company that develops, markets, and sells innovative medtech products for the global market. The company is committed to improving patient welfare and outcomes, increasing clinical data accuracy, and promoting positive health economics. It is building a scalable medtech platform that combines a portfolio of proprietary products with strategic partnerships, leveraging its manufacturing, development, regulatory, and commercial capabilities to bring new technologies to market.

Recent filings

Filing Released Lang Actions
Observe Medical - Milestone production capacity reached for UnoMeter 500
Regulatory Filings Classification · 95% confidence The document is a short press release dated December 12, 2023, announcing a specific operational milestone: reaching a production capacity equivalent to a historical benchmark (Convatec's level for UnoMeter 500). It includes quotes from the CEO and contact information, characteristic of a news announcement rather than a comprehensive regulatory filing (like 10-K or IR) or a formal earnings release (ER). Since it is a general operational update that doesn't fit the specific categories like M&A (TAR), Capital (CAP), or Director Dealing (DIRS), it falls best under the general Regulatory Filings/Announcements category, RNS, which serves as a fallback for significant, non-standard corporate news releases.
2023-12-12 English
Observe Medical - Milestone production capacity reached for UnoMeter 500
Regulatory Filings Classification · 95% confidence The document is a short press release dated December 12, 2023, announcing a specific operational milestone: reaching a production capacity equivalent to a competitor (Convatec) for their product UnoMeter 500. It includes quotes from the CEO and contact information. This type of announcement, which is not a full financial report (10-K, IR, ER), a management change (MANG), or a dividend notice (DIV), fits best under the general category for regulatory announcements or news releases that don't fit elsewhere. Given the options, 'Regulatory Filings' (RNS) serves as the appropriate fallback for general, non-standardized corporate news releases that convey material information but do not match the specific definitions like ER, CT, or MANG. It is too specific for RNS, but RNS is the best fit among the provided codes for a general operational update announcement that isn't a formal financial filing or specific corporate action.
2023-12-12 English
OBSERVE MEDICAL ASA - Last day of the subscription period in the rights issue
Share Issue/Capital Change Classification · 99% confidence The document is an announcement from Observe Medical ASA regarding the 'Last day of the subscription period in the rights issue'. It explicitly mentions a 'rights issue' of new shares, the subscription price, the approval of a 'prospectus' by the Financial Supervisory Authority of Norway, and the impending expiry of the subscription period. This content directly relates to fundraising, capital structure changes, and the offering of securities, which aligns perfectly with the definition of a Capital/Financing Update (CAP). It is not a full annual report (10-K), an earnings release (ER), or a general regulatory filing (RNS), as it details a specific corporate financing event.
2023-12-12 English
OBSERVE MEDICAL ASA - Last day of the subscription period in the rights issue
Share Issue/Capital Change Classification · 99% confidence The document is an announcement titled "OBSERVE MEDICAL ASA - Last day of the subscription period in the rights issue." It explicitly discusses a 'rights issue' involving the offering and subscription of new shares, referencing a Prospectus approved by the Financial Supervisory Authority of Norway. A rights issue is a specific type of corporate financing activity aimed at raising capital by offering existing shareholders the right to purchase additional shares. This directly aligns with the definition of 'Capital/Financing Update' (CAP). It is not a full annual report (10-K), an earnings release (ER), or a general regulatory filing (RNS), as it pertains to a specific, defined financing event.
2023-12-12 English
Observe Medical ASA - Exercise of subscription rights and over-subscription by primary insider and close associate of primary insider
Director's Dealing Classification · 98% confidence The document explicitly details the exercise of subscription rights and over-subscription by a primary insider (CEO Rune Nystad) and a closely associated person, resulting in the allocation of new offer shares via a Rights Issue. This transaction involves personal share dealings by a director/executive. This directly aligns with the definition of Director's Dealing (insider trades). The filing mentions disclosure requirements under MAR Article 19, which mandates reporting of transactions by persons discharging managerial responsibilities. Therefore, the appropriate code is DIRS.
2023-12-11 English
Observe Medical ASA - Exercise of subscription rights and over-subscription by primary insider and close associate of primary insider
Director's Dealing Classification · 100% confidence The document text is titled "NOTIFICATION BY PRIMARY INSIDERS/ CLOSE ASSOCIATE" and details transactions (specifically, the exercise of subscription rights) conducted by a Chief Executive Officer (CEO) and a closely associated person. This type of mandatory disclosure regarding personal share transactions by company directors and executives directly corresponds to the definition of Director's Dealing (DIRS). It is not an Annual Report (10-K), an Earnings Release (ER), or a general Regulatory Filing (RNS), as it is highly specific to insider trading/dealing disclosure.
2023-12-11 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.